Diagnostic Technology Panel- What’s new and exciting in diagnosis

Presented by: Momo Vuyisich, PhD; Guru Banavar, PhD; Sri Venkatesh Ganeshan, MD; and Mark Cannon, DDS

Description
Panel discussion- led by Dr. Mark Cannon, researchers will discuss the diagnostic tests and Dr. Cannon will explain clinical uses.

Dr Vuyisich will describe the concept of systems biology and clinical tests that his company has developed to digitize the chemistry of the human body, which includes human and microbial physiology.

Learning Objectives
- systems biology
- human microbiome
- RNA vs DNA in chronic diseases
- (meta)transcriptomic analyses
- bioinformatics
- taxonomic classification
- CLIA-licensed tests

Bio
Mark Cannon, DDS
Mark L. Cannon received his Doctorate of Dental Surgery from the University of Nebraska and then attended Northwestern University for his Masters of Pediatric Dentistry. He completed his residency at Children’s Memorial Hospital and received his Diplomate status by the American Board of Pediatric Dentistry. He is a past president of the Illinois Society of Dentistry for Children, a Professor of Otolaryngology, Division of Dentistry at Northwestern University, Feinberg School of Medicine, and a member of the International Association of Pediatric Dentistry. In addition to maintaining a large private practice in the suburbs of Chicago, he is the Research Coordinator of the residency program at Ann and Robert Lurie Children’s Hospital, Chicago, Illinois. Dr. Cannon has presented guest lectures at the University of Athens, Greece, Sao Paulista State University, UNESP, Aracatuba, Brazil, University of Texas- Houston, University of Alabama-Birmingham, and at the University of Illinois, Chicago, Department of Pediatric Dentistry.

Dr. Momo Vuyisich
Momo Vuyisich is a founder and Chief Science Officer of Viome. He is also an Adjunct Professor at the University of New Mexico and New Mexico Tech. Besides providing scientific leadership at Viome, Momo focuses on product development, clinical accreditation, and clinical research.

Besides providing scientific leadership, I focus on product development, conversion of RUO assays into CLIA LDTs, and clinical research. I am also an Adjunct Professor at University of New Mexico (UNM) and New Mexico Tech (NMT).

Before founding Viome, I worked for 12 years as a scientist at Los Alamos National Laboratory (LANL), where I was the leader of the Applied Genomics team. My team's research focused on developing and applying modern genomics to the areas of gut microbiomes, host-pathogen interactions, microbial inter-species interactions, pathogen detection, cancer biology, toxicology, infectious diseases, antibiotic resistance, forensics, etc. I also helped set up several turn-key genome centers in Africa and Asia, and provided complete staff training in laboratory methods and bioinformatic analyses.

Dr. Guru Banavar
Dr. Guru Banavar leads the development of Viome’s AI-based platform for delivering precision recommendations to deter chronic disease. The core of this platform is based on extracting novel insights from large gene expression datasets (from stool, blood, and saliva samples), and from clinical studies targeting disorders including metabolic, gastrointestinal, immunological, neurological, and cancer. Previously, Guru led IBM’s Watson AI Research, and has developed and commercialized advanced technology solutions in multiple industries.

Guru is a recognized thought leader who delivered the 2017 Turing Lecture, and has spoken on the Nobel stage (twice), the Aspen Ideas Festival, and the Milken Conference. He received a national innovation award from the President of India, and other awards for leadership in technology management. He holds more than 30 US patents, has published extensively, and has been featured in international media including the New York Times, the Economist, the Wall Street Journal, BBC, and NPR.

Dr. Sri Venkatesh Ganeshan
Dr. Sri Venkatesh Ganeshan MD serves as Chief Medical Officer to Iliad. A graduate of the All India Institute of Medical Sciences, New Delhi, India, Dr. Ganeshan’s expertise resides in the therapeutic areas of Oncology, Urology, Transplant, Immunology, Dermatology, Hepatology, Virology and Neurodegenerative disorders.

Dr. Geneshan has vast experience in delivering organizational goals through project leadership, extensive clinical and administrative experience, and thorough knowledge of multiple therapeutic areas. As a former executive at Astellas Pharma US, Dr. Ganeshan launched two first in class compounds with great success. Successful in recognition of opportunities and facilitation of efforts to improve process, product knowledge and clinical outcome, Sri has proven ability in building productive associations with clinicians, researchers and administrators in pursuit of expanded understanding of disease and treatment options. Dr. Ganeshan brings extensive Clinical trial study management and regulatory affairs experience to Iliad, including clinical trial design, study medical monitoring, pharmacovigilance, and vendor management. Dr. Geneshan is discussing mitochondrial health determination by buccal cheek swabs.